Protection against HIV with Kocitaf
Human Immunodeficiency Virus (HIV) requires both awareness and proactive measures for effective management. HIV attacks the immune system, specifically CD4 cells, which help the immune system ward off infections. As the virus progresses, it weakens the immune system, making the body susceptible to various infections and diseases. The initial stages of HIV may not manifest noticeable symptoms; however, as the infection progresses, individuals may experience symptoms such as fatigue, unintentional weight loss, swollen lymph nodes, and recurrent infections. HIV is primarily transmitted through unprotected sexual intercourse, sharing needles or syringes, and from an infected mother to her child during childbirth or breastfeeding.
Preventing HIV involves a combination of safe practices and, in some cases, medications like Kocitaf. Safe practices include consistent and correct use of condoms, regular HIV testing, and avoiding sharing needles.
Prevention using Kocitaf
Kocitaf is one of the PEP medications (post-exposure prophylaxis) used in the treatment and prevention of HIV. Each tablet of Kocitaf contains a combination of three active ingredients: Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate. Dolutegravir inhibits HIV integrase, an enzyme essential for the replication of the virus, by blocking the process of viral DNA integration. Emtricitabine and Tenofovir Alafenamide Fumarate, both are nucleoside reverse transcriptase inhibitors (NRTIs), work by incorporating into viral DNA and terminating its replication.
Kocitaf is taken once daily and should be started as soon as possible, and not later than 72 hours after potential exposure to HIV. It is important to follow the prescribed dosage and complete the full course of treatment to effectively prevent the development of HIV infection.
If you miss a dose within 18 hours of the usual time, take the missed dose as soon as possible and resume the normal dosing schedule. If more than 18 hours have passed, do not take the missed dose and continue with the regular dosing schedule. If you vomit within 1 hour of taking Kocitaf, take another tablet as soon as possible.
Common side effects of Kocitaf may include nausea, diarrhea, headache, and fatigue. However, not everyone experiences these side effects, and they tend to be temporary and mild. The medication can be taken with or without food, but nausea is often worse on an empty stomach.
The usual duration of Kocitaf for PEP is 28 days, but it may vary depending on the individual’s situation and the nature of potential exposure to HIV. It’s important to follow the recommended treatment course prescribed by your healthcare provider.